CatalYm has commenced dosing the first subject in its Phase II/III VINCIT trial, assessing the safety and efficacy of its ...

CatalYm today announced that the first patient has been dosed in the Phase 2/3 VINCIT trial (Visugromab IN Cachexia ...

Understanding the importance of using the right diagnostic criteria for cachexia is crucial, as it can significantly influence the health and survival of cancer patients. Maintaining good health and ...

New research in fruit flies suggests that a decreased desire to eat protein can serve as the earliest known warning sign of ...

Cachexia meaning: Today’s word of the day is 'cachexia', which is a medical term that describes a serious condition of extreme physical wasting and malnutrition usually linked to chronic illness. The ...

PanCAN PurpleStride Chicago welcomes first time Premier Sponsor Endevica Bio, who is dedicated to advancing novel treatments ...

Cachexia in older SCLC patients leads to inferior survival rates and increased treatment complications, such as dose reductions and incomplete chemotherapy courses. Patients with cachexia had ...

Curanex Pharmaceuticals Inc. CURX on Monday said that a recent patient case study may reinforce its strategic push into cancer cachexia, a severe wasting condition tied to advanced cancers with ...